RE-BVS – Piemonte Repository

Sfoglia per AUTORE
GASPARRO D
Collezione AOU Alessandria

Items : 4

Real-world experience of abiraterone acetate plus prednisone in chemotherapy-naive patients with metastatic castration-resistant prostate cancer: long-term results of the prospective ABItude study. in ESMO open / ESMO Open. 2022 Apr;7(2):100431. doi: 10.1016/j.esmoop.2022.100431. Epub 2022 Apr 8.

2022
AOU Alessandria
AOU Città della Salute di Torino

Beccaglia P; Schips L; Aglietta M; Nova P; Carella C; Guglielmini PF; Ludovico GM; Gasparro D; Galli L; Airoldi M; De Placido S; Rossetti S; Cinieri S; Bordonaro R; Maisano R; Alitto AR; Chiuri VE; Giordano M; Procopio G; Sciarra A; Livi L; Santini D;

Effects of abiraterone acetate plus prednisone on bone turnover markers in chemotherapy-naïve mCRPC patients after ADT failure: A prospective analysis of the italian real-world study ABITUDE. in Journal of bone oncology / J Bone Oncol. 2020 Dec 2;26:100341. doi: 10.1016/j.jbo.2020.100341. eCollection 2021 Feb.

2021
AOU Alessandria

Panebianco F; Carlini P; Sartori D; Lanzetta G; Mencoboni M; Acquati M; Fagnani D; Ceresoli GL; D'Angelillo RM; Chiuri VE; Guglielmini PF; Bordonaro R; Gasparro D; Cinieri S; Santini D; Beccaglia P; Procopio G;

Incidence and outcomes of severe acute respiratory syndrome coronavirus 2 infection in patients with metastatic castration-resistant prostate cancer. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2020 Nov;140:140-146. doi: 10.1016/j.ejca.2020.09.018. Epub 2020 Oct 20.

2020
AOU Alessandria

Caffo O; Gasparro D; Di Lorenzo G; Volta AD; Guglielmini P; Zucali P; Bortolus R; Cavo A; Ceresoli G; Chiari R; Fornarini G; Fratino L; Iaculli A; Maruzzo M; Masini C; Morelli F; Mucciarini C; Procopio G; Sabbatini R; Verri E; Kinspergher S; Maines F; Messina C; Veccia A; Donini M;

Effectiveness of abiraterone acetate plus prednisone in chemotherapy-naïve patients with metastatic castration-resistant prostate cancer in a large prospective real-world cohort: the ABItude study. in Therapeutic advances in medical oncology / Ther Adv Med Oncol. 2020 Oct 29;12:1758835920968725. doi: 10.1177/1758835920968725. eCollection 2020

2020
AOU Alessandria
AOU Città della Salute di Torino

Sciarra A; Livi L; Beccaglia P; Schips L; Aglietta M; Naglieri E; Fagnani D; Guglielmini P; Ludovico GM; Gasparro D; Airoldi M; Sbrana A; De Placido S; Facchini G; Bordonaro R; Calvani N; Maisano R; Mantini G; Giordano M; Chiuri VE; Procopio G; Santini D;